Suppr超能文献

特发性肺动脉高压中右心逆向重构的预后相关性

Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension.

作者信息

Badagliacca Roberto, Poscia Roberto, Pezzuto Beatrice, Papa Silvia, Reali Manuela, Pesce Francesca, Manzi Giovanna, Gianfrilli Daniele, Ciciarello Francesco, Sciomer Susanna, Biondi-Zoccai Giuseppe, Torre Roberto, Fedele Francesco, Vizza Carmine Dario

机构信息

Departments of Cardiovascular and Respiratory Sciences, Sapienza University of Rome, Rome, Italy.

Departments of Cardiovascular and Respiratory Sciences, Sapienza University of Rome, Rome, Italy.

出版信息

J Heart Lung Transplant. 2017 Oct 2. doi: 10.1016/j.healun.2017.09.026.

Abstract

BACKGROUND

Right ventricular (RV) failure is a major determinant of symptoms and shortened survival in pulmonary arterial hypertension (PAH). This study assessed the prognostic relevance of increased right heart (RH) dimensions determined by echocardiography and RH reverse remodeling (RHRR) with targeted therapies in idiopathic PAH (IPAH).

METHODS

The study prospectively monitored 102 therapy-naïve IPAH patients for the presence of clinical worsening. Baseline evaluation included RH catheterization and echocardiography. RHRR at the 1-year follow-up was defined by a decrease in RV end-diastolic area, right atrial area, and the left ventricular systolic eccentricity index.

RESULTS

At the 1-year follow-up, 18 of 102 patients (17.6%) presented with RHRR. A decrease in pulmonary vascular resistance was the only independent determinant of RHRR. The 94 surviving patients were monitored for 995 ± 529 days. RHRR was an independent prognostic factor and significantly improved the power of the prognostic model based on traditional clinical and hemodynamic parameters. The respective event-free survival rates at 1, 3, and 5 years were 94%, 94%, and 94% in patients with RHRR and 75%, 55%, and 24% in those without RHRR (p = 0.0001). Interestingly, RHRR was able to further stratify patients' risk assessment through the Registry to Evaluate Early And Long-term PAH Disease Management risk score.

CONCLUSIONS

RHRR after 1 year of treatment is an independent predictor of prognosis in IPAH. The likelihood of RHRR is proportional to decreased pulmonary vascular resistance.

摘要

背景

右心室衰竭是肺动脉高压(PAH)患者症状和生存期缩短的主要决定因素。本研究评估了超声心动图测定的右心(RH)维度增加及特发性PAH(IPAH)靶向治疗后的RH逆向重构(RHRR)的预后相关性。

方法

本研究前瞻性监测了102例未经治疗的IPAH患者临床恶化情况。基线评估包括RH导管插入术和超声心动图检查。1年随访时的RHRR定义为右心室舒张末期面积、右心房面积和左心室收缩期偏心指数降低。

结果

1年随访时,102例患者中有18例(17.6%)出现RHRR。肺血管阻力降低是RHRR的唯一独立决定因素。对94例存活患者进行了995±529天的监测。RHRR是一个独立的预后因素,显著提高了基于传统临床和血流动力学参数的预后模型的预测能力。RHRR患者1年、3年和5年的无事件生存率分别为94%、94%和94%,无RHRR患者分别为75%、55%和24%(p = 0.0001)。有趣的是,RHRR能够通过肺动脉高压疾病管理早期和长期评估注册风险评分进一步分层患者的风险评估。

结论

治疗1年后的RHRR是IPAH预后的独立预测因素。RHRR的可能性与肺血管阻力降低成正比。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验